An obvious increase of plasma Hsp90α concentrations in patients with early-stage breast cancer (stages I and II; median 64.53 ng/mL, mean 72.11 ng/mL) was noticed compared with those in the non-cancer group (Figure 1D and Supplementary Table S5). This evidence concerns the gene HSP90AA1 and breast cancer.